Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment
Cancers · 14.01.2026 · 18 (2) · 254
DOI: 10.3390/cancers18020254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 14.01.2026. Verfasst von Hazem Abdullah und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program, Nucana (United Kingdom), NuCana plc.
Abstract (Originalsprache)
Background
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer and is marked by pronounced intra-tumoural heterogeneity that complicates therapeutic response. Patient-derived organoids offer a physiologically relevant model to capture this diversity and evaluate treatment effects. When integrated with spatial transcriptomics, they might enable the mapping of spatially resolved transcriptional and isoform-level changes within the tumour microenvironment.
Methods
We established a robust workflow for generating patient-derived ccRCC organoids, that are not passaged and retain original cellular components. These retain key features of the original tumours, including cancer cell, stromal, and immune components.
Results
Spatial transcriptomic profiling revealed multiple transcriptionally distinct regions within and across organoids, reflecting the intrinsic heterogeneity of ccRCC. Isoform-level analysis identified spatially variable expression of glutaminase (GLS) isoforms, with heterogeneous distributions of both the GAC and KGA variants. Treatment with NUC-7738, a phosphoramidate derivative of 3′-deoxyadenosine, induced marked transcriptional remodelling of organoids, including alterations in ribosomal and mitochondrial gene expression.
Conclusions
This study demonstrates that combining long-read spatial transcriptomics with patient-derived organoid models provides a powerful and scalable approach for dissecting gene and isoform-level heterogeneity in ccRCC and for elucidating spatially resolved transcriptional responses to novel therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of St Andrews, North Haugh, St Andrews KY16 9TF, UK.
- Pathology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.
- Edinburgh Urological Cancer Group, Institute of Genetics and Molecular Medicine, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.
- NuCana plc, 3, Lochside Way, Edinburgh EH12 9DT, UK.
ORCID-Profile: Hazem Abdullah, Ying Zhang, Alexander Laird, Peter Mullen, David J Harrison, Mustafa Elshani
Förderung
- European Union's Horizon 2020 research and innovation program
- Nucana (United Kingdom)
- NuCana plc
- University of St Andrews Sanctuary Scholarship
- European Union’s Horizon 2020 research and innovation programme
Zitieren
APA
Abdullah, H., Zhang, Y., Kirkwood, K., Laird, A., Mullen, P., Harrison, D. J., & Elshani, M. (2026). Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment. Cancers, 18(2), 254. https://doi.org/10.3390/cancers18020254
Vancouver
Abdullah H, Zhang Y, Kirkwood K, Laird A, Mullen P, Harrison DJ, et al. Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment. Cancers. 2026;18(2):254. doi:10.3390/cancers18020254
BibTeX
@article{Abdullah2026,
author = {Abdullah, Hazem and Zhang, Ying and Kirkwood, Kathryn and Laird, Alexander and Mullen, Peter and Harrison, David J and Elshani, Mustafa},
title = {Long-Read Spatial Transcriptomics of Patient-Derived Clear Cell Renal Cell Carcinoma Organoids Identifies Heterogeneity and Transcriptional Remodelling Following NUC-7738 Treatment},
journal = {Cancers},
year = {2026},
volume = {18},
number = {2},
pages = {254},
doi = {10.3390/cancers18020254}
}
EUVIMED